Latest Breaking News On - Severe psoriasis - Page 1 : comparemela.com

New evidence confirms patients with severe psoriasis are at a higher risk for heart disease

New evidence confirms patients with severe psoriasis are at a higher risk for heart disease
medicalxpress.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from medicalxpress.com Daily Mail and Mail on Sunday newspapers.

Stefano piasericoUniversity of padovaDepartment of medicineDermatology unitPsoriasis area severity indexCoronary microvascular dysfunctionAsymptomatic patientsSevere psoriasisInvestigative dermatology

Health Problems Linked to Psoriasis

Psoriasis puts you at risk for other health problems, too. Find out what symptoms to be on the lookout for and ways you may be able to prevent some of them.

United statesJont gilesAmerican college of rheumatologyNational kidney foundationNational psoriasis foundationArthritis foundationColumbia university school of medicineNational eye instituteAmerican academy of dermatologyNews networkUc davis health systemPsoriatic arthritis allianceDermatology researchPsoriasis foundationLink psoriasisPsoriatic arthritis

Acute Pancreatitis Pipeline Assessment (2023) Covering

Acute Pancreatitis Pipeline Assessment (2023) Covering
openpr.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from openpr.com Daily Mail and Mail on Sunday newspapers.

United kingdomUnited statesPsoriasis market insightsSevere psoriasisDownload sample reportSevere psoriasis overview

AbbVie Showcases Strength of Dermatology Portfolio with New Data Presented at the 2023 AAD Annual Meeting

/PRNewswire/ AbbVie (NYSE: ABBV) today announced it will present more than 20 abstracts, including one late-breaking presentation during the 2023 American.

Mississippi riverUnited statesNew orleansHidradenitis suppurativaCeline goldbergerBoehringer ingelheimExchange commissionAmerican academy of dermatologyAbbvie incPoster centerAnnual meetingAll timesPsoriasis patients switchingRisankizumab afterIxekizumab afterBreaking oral presentation

AbbVie Showcases New Analyses and Real-World Data Across Multiple Immune-Mediated Skin Diseases at the European Academy of Dermatology and Venereology (EADV) 2022 Congress

Analyses highlight long-term efficacy and safety results, including real-world data, from studies of SKYRIZI® (risankizumab) in moderate to severe.

United statesChiedzo mpofuGlobal medical affairsEuropean academy of dermatologyEpidemiologic survey on prevalence of genital psoriasisBoehringer ingelheimFree communications in atopic dermatitis sessionEuropean academyAll timesPsoriasis patients participatingPsoriasis patients who hadTerm safetyIsevere plaque psoriasisInterim analysisOpen label extensionLong term risankizumab treatment